Investment and recruitment announced at Cheshire biotech group

Dr Michael Carter
A Cheshire biotech company has completed a £300,000 fundraising, and appointed a new non-executive director to its board. BiVictriX Therapeutics, based in Alderley Park, has successfully completed an internal fundraising round, in which all major shareholders participated. These included the existing institutional shareholders, Alderley Park Ventures and Development Bank Wales, as well as existing and new high net worth individuals. The funding will allow the company to complete non-clinical studies in preclinical models of ... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...